# Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/updated-results-from-monaleesa-2-a-phase-iii-trial-of-first-line-ribociclib-plus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gabriel N. Hortobágyi,Salomon M. Stemmer,H. A. Burris,Yoon Sim Yap,Gabe S. Sonke,Shani Paluch–Shimon,Mario Campone,Katarína Petráková,Kim T. Blackwell,Eric P. Winer,W Janni,S. Verma,PierFranco Conte,Carlos L. Arteaga,David Cameron,S. Mondal,Faye Su,Marshall G. Miller,Mohamed Elmeliegy,Caroline Germa,Joyce O’Shaughnessy |
| Citations | 876 |
| DOI | 10.1093/annonc/mdy155 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/20.500.11820/d05c713d-b2c6-4bb2-b06c-bd54c84fcc5a |
| OpenAlex ID | https://openalex.org/W2802776309 |
| PMID | 29718092 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Joyce O’Shaughnessy](https://scholariq.org/researchers/joyce-o-shaughnessy/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.